The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

Almost half of councils in England risk falling into bankruptcy without action to address a £4.6bn deficit amassed under a ...

Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...

GSK boss Walmsley (left) received £10.6m in salary and bonuses in 2024 while Blanc (right), head of insurance group Aviva, ...

One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...

GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...

UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...

The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...